Recent advances in the development of personalized cell therapies, from campus laboratories to bio-manufacturing and human use, will be examined at the Tuesday, June 26 Tech Council Innovation Network luncheon meeting in Madison.
The luncheon will be held at the Sheraton Hotel on Madison’s John Nolen Drive. Registration and networking begin at 11:30 a.m., lunch at noon and the presentation at 12:30 p.m. The cost is $10 for students and returning veterans, $25 for individual members, $35 for non-members and included for Tech Council corporate members. Click here to register.
Dr. Jacques Galipeau, assistant dean for therapeutics discovery at the University of Wisconsin Medical School and the director of its new program for advanced cell therapy, will speak.
The goal of the program is to develop personalized cell therapies for immune and malignant disorders and to promote and deploy first-in-human clinical trials of UW cell therapy innovations to improve outcomes for children and adults. This approach utilizes a patient’s own cells and tissues, which undergo biological augmentation for treatment of their specific disease.
“Dr. Galipeau will discuss, in lay-person terms, the resources available at UW-Madison that make it possible to push the envelope of cell therapy while increasing the potential for therapies and entrepreneurial spin-offs,” said Tom Still, president of the Wisconsin Technology Council. “It is part of a revolution in medical care that is coming faster than one might imagine.”
The Wisconsin Technology Council is the independent, non-profit science and technology adviser to the governor and Legislature, with events, publications and outreach that contribute to Wisconsin’s tech-based economy. To join, go to www.wisconsintechnologycouncil.com or call 608-442-7557.